title: Cost-effectiveness of cyclooxygenase-2 inhibitors in chronic arthritis.
authors.forename: James M
authors.initials: JM
authors.lastname: Pellissier
authors.forename: Douglas J
authors.initials: DJ
authors.lastname: Watson
authors.forename: Sheldon X
authors.initials: SX
authors.lastname: Kong
authors.forename: Walter L
authors.initials: WL
authors.lastname: Straus
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000191:economics*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D003362:Cost-Benefit Analysis; D051546:Cyclooxygenase 2; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors / Q000191:economics*; D006801:Humans; D007527:Isoenzymes / Q000191:economics*; D008565:Membrane Proteins; D010003:Osteoarthritis / Q000188:drug therapy*; D011451:Prostaglandin-Endoperoxide Synthases / Q000191:economics*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors; D007527:Isoenzymes; D008565:Membrane Proteins; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D011451:Prostaglandin-Endoperoxide Synthases